Literature DB >> 25791478

SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling.

Jun Xu1, Hui-Yan Sun2, Feng-Jun Xiao2, Hua Wang2, Yang Yang3, Lu Wang4, Chun-Ji Gao4, Zi-Kuan Guo2, Chu-Tse Wu5, Li-Sheng Wang6.   

Abstract

SUMO/sentrin specific protease 1 (Senp1) is an important regulation protease in the protein sumoylation, which affects the cell cycle, proliferation and differentiation. The role of Senp1 mediated protein desumoylation in pathophysiological progression of multiple myeloma is unknown. In this study, we demonstrated that Senp1 is overexpressed and induced by IL-6 in multiple myeloma cells. Lentivirus-mediated Senp1 knockdown triggers apoptosis and reduces viability, proliferation and colony forming ability of MM cells. The NF-κB family members including P65 and inhibitor protein IkBα play important roles in regulation of MM cell survival and proliferation. We further demonstrated that Senp1 inhibition decreased IL-6-induced P65 and IkBα phosphorylation, leading to inactivation of NF-кB signaling in MM cells. These results delineate a key role for Senp1in IL-6 induced proliferation and survival of MM cells, suggesting it may be a potential new therapeutic target in MM.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-6; Multiple myeloma; NF-кB; Senp1

Mesh:

Substances:

Year:  2015        PMID: 25791478     DOI: 10.1016/j.bbrc.2015.03.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 2.  Targeting nuclear thymidylate biosynthesis.

Authors:  James Chon; Patrick J Stover; Martha S Field
Journal:  Mol Aspects Med       Date:  2016-11-19

Review 3.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

4.  Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation.

Authors:  Maria Dafne Cardamone; Bogdan Tanasa; Carly T Cederquist; Jiawen Huang; Kiana Mahdaviani; Wenbo Li; Michael G Rosenfeld; Marc Liesa; Valentina Perissi
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

5.  SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.

Authors:  Wenwen Zhang; Huiyan Sun; Xuefeng Shi; Hua Wang; Chunping Cui; Fengjun Xiao; ChuTse Wu; Xiaozhong Guo; Lisheng Wang
Journal:  Tumour Biol       Date:  2015-12-22

6.  Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer.

Authors:  Keyuan Liu; Jing Zhang; Hao Wang
Journal:  J Clin Lab Anal       Date:  2018-07-24       Impact factor: 2.352

Review 7.  SENP Proteases as Potential Targets for Cancer Therapy.

Authors:  Paulina Tokarz; Katarzyna Woźniak
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

8.  Senp1 drives hypoxia-induced polycythemia via GATA1 and Bcl-xL in subjects with Monge's disease.

Authors:  Priti Azad; Huiwen W Zhao; Pedro J Cabrales; Roy Ronen; Dan Zhou; Orit Poulsen; Otto Appenzeller; Yu Hsin Hsiao; Vineet Bafna; Gabriel G Haddad
Journal:  J Exp Med       Date:  2016-11-07       Impact factor: 14.307

9.  SENP1-Mediated Desumoylation of DBC1 Inhibits Apoptosis Induced by High Glucose in Bovine Retinal Pericytes.

Authors:  Jian Gao; Xia Chen; Qing Gu; Xiaoxiao Liu; Xun Xu
Journal:  J Ophthalmol       Date:  2016-03-27       Impact factor: 1.909

Review 10.  SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.

Authors:  Karolin Eifler; Alfred C O Vertegaal
Journal:  Trends Biochem Sci       Date:  2015-10-22       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.